Sonova Sharpens Hearing-Care Focus, Sets CHF 6 Billion Sales Target by 2030/31

The latest update is out from Sonova Holding AG ( (CH:SOON) ).

Sonova has unveiled a sharpened strategy to reinforce its market leadership in hearing care by fully focusing on hearing aids and cochlear implants and exiting its Consumer Hearing business under the Sennheiser brand. Management targets revenue of CHF 6 billion by 2030/31, backed by mid‑term annual growth ambitions of 5–10% for sales and 7–12% for core EBIT, with margin gains driven by operating leverage and structural savings.

The plan rests on three pillars: boosting usage of hearing solutions through lifestyle‑oriented design, AI‑enhanced and connected products, and Asia expansion; winning locally via a tightly managed multi‑brand, multi‑channel setup and accelerated retail acquisitions; and optimizing operations around on‑time, high‑quality, cost‑efficient delivery. Sonova confirmed its outlook for 2025/26, guiding growth to the lower end of prior ranges while reporting solid momentum and market share gains in wholesale, signaling a transitional but strategically confident phase for investors and other stakeholders.

By divesting Consumer Hearing, Sonova aims to concentrate capital and management attention on core medical hearing segments whose demand is supported by demographic trends and rising awareness. Closer coordination between wholesale and retail, shared lead generation, and broader use of R&D synergies between hearing aids and cochlear implants are designed to speed innovation cycles, deepen customer loyalty and further differentiate Sonova in an increasingly competitive global hearing-care landscape.

The most recent analyst rating on (CH:SOON) stock is a Buy with a CHF196.00 price target. To see the full list of analyst forecasts on Sonova Holding AG stock, see the CH:SOON Stock Forecast page.

More about Sonova Holding AG

Sonova Holding AG is a Swiss-based global leader in innovative hearing solutions, spanning personal audio devices, wireless communication products, audiological services, hearing aids and cochlear implants. Operating in more than 100 countries under brands such as Phonak, Unitron, AudioNova, Sennheiser (under license) and Advanced Bionics, the group generated CHF 3.9 billion in revenue in 2024/25 and employs about 18,000 people.

The company benefits from structurally attractive demographics and low penetration of hearing solutions, positioning it to capture rising demand as awareness, technology adoption and healthy aging trends expand its addressable market. Its vertically integrated model, combining wholesale and retail networks, and its recognized innovation strength underpin its ambition to grow faster than the industry and reinforce its leadership in hearing care.

Average Trading Volume: 170,205

Technical Sentiment Signal: Sell

Current Market Cap: CHF10.27B

Learn more about SOON stock on TipRanks’ Stock Analysis page.